T Cell Immune Responses to Chlamydia trachomatis in South African AGYW

Overview

This study characterized systemic and mucosal immune responses to Chlamydia trachomatis among South African adolescent girls and young women (AGYW). Findings reveal that women with untreated or recurrent infection exhibit increased cervical T cell activation but diminished systemic multifunctional CD4+ T cell responses, suggesting immune modulation with repeated exposure.

Background

Chlamydia trachomatis is the most common bacterial sexually transmitted infection worldwide, disproportionately affecting adolescent girls and young women. Despite effective antibiotic treatments, many infections remain undiagnosed and untreated, especially in low- and middle-income countries. Vaccine development is challenged by incomplete understanding of protective immunity and the risk of immunopathology. CD4+ T cells, particularly Th1 responses, are critical for immunity, but their role in natural infection and repeated exposure contexts remains unclear.

Data Highlights

Key Findings

• Women with NAAT+/Ab+ status showed increased cervical T cell activation, indicating mucosal immune activation during untreated or recurrent infection.
• The magnitude of systemic C. trachomatis-specific CD4+ T cell responses was 2.4-fold lower in NAAT+/Ab+ women compared to those with cleared or primary infection.
• Multifunctional CD4+ T cells specific to C. trachomatis were highest in women who had cleared infection (NAAT-/Ab+) and nearly absent in those with untreated/recurrent infection (NAAT+/Ab+).
• Systemic Th1 responses inversely correlated with genital tract inflammatory cytokines such as IL-1β, TNF, and IL-17A, suggesting a role in limiting mucosal inflammation.
• The quality and magnitude of systemic CD4+ T cell responses may be critical for protective immunity and reducing immunopathology in high-risk populations.

Clinical Implications

These findings highlight the importance of robust systemic multifunctional CD4+ T cell responses in controlling Chlamydia trachomatis infection and limiting mucosal inflammation. Monitoring T cell activation and cytokine profiles could inform risk stratification and guide vaccine development strategies aimed at inducing protective immunity without exacerbating genital tract pathology.

Conclusion

The study demonstrates that repeated or untreated Chlamydia trachomatis infections in AGYW are associated with altered systemic and mucosal immune responses, underscoring the need for vaccines that elicit strong multifunctional CD4+ T cell immunity to achieve effective protection and reduce immunopathology.

References

1. WHO 2020 -- Global prevalence and incidence of Chlamydia trachomatis
2. WISH Study -- Women's Initiative in Sexual Health cohort data
3. Clinical Immunology Research -- Role of CD4+ T cells in Chlamydia immunity